Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

The Incapacity of the Surgeon to Identify NASH in Bariatric Surgery Makes Biopsy Mandatory (2009)

  • Authors:
  • USP affiliated authors: ALBUQUERQUE, LUIZ AUGUSTO CARNEIRO D - FM
  • USP Schools: FM
  • DOI: 10.1007/s11695-009-9980-x
  • Subjects: OBESIDADE MÓRBIDA (CIRURGIA;EPIDEMIOLOGIA); CUIDADOS PRÉ-OPERATÓRIOS; FÍGADO (PATOLOGIA); HAPATOPATIAS (PATOLOGIA); CIRURGIA BARIÁTRICA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s11695-009-9980-x (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Versões disponíveis em Acesso Aberto do: 10.1007/s11695-009-9980-x (Fonte: Unpaywall API)

    Título do periódico: Obesity Surgery

    ISSN: 0960-8923,1708-0428



      Não possui versão em Acesso aberto
    Informações sobre o Citescore
  • Título: Obesity Surgery

    ISSN: 0960-8923

    Citescore - 2017: 2.92

    SJR - 2017: 1.396

    SNIP - 2017: 1.219


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM2338335-10BECEP 001 2009
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      TEIXEIRA, Antônio Roberto Franchi; BELLODI-PRIVATO, Marta; CARVALHEIRA, José Barreto; et al. The Incapacity of the Surgeon to Identify NASH in Bariatric Surgery Makes Biopsy Mandatory. Obesity surgery, Oxford, v. 19, n. 12, p. 1678-1684, 2009. Disponível em: < http://link.springer.com/article/10.1007/s11695-009-9980-x > DOI: 10.1007/s11695-009-9980-x.
    • APA

      Teixeira, A. R. F., Bellodi-Privato, M., Carvalheira, J. B., Pilla, V. F., Pareja, J. C., & D´Albuquerque, L. A. C. (2009). The Incapacity of the Surgeon to Identify NASH in Bariatric Surgery Makes Biopsy Mandatory. Obesity surgery, 19( 12), 1678-1684. doi:10.1007/s11695-009-9980-x
    • NLM

      Teixeira ARF, Bellodi-Privato M, Carvalheira JB, Pilla VF, Pareja JC, D´Albuquerque LAC. The Incapacity of the Surgeon to Identify NASH in Bariatric Surgery Makes Biopsy Mandatory [Internet]. Obesity surgery. 2009 ; 19( 12): 1678-1684.Available from: http://link.springer.com/article/10.1007/s11695-009-9980-x
    • Vancouver

      Teixeira ARF, Bellodi-Privato M, Carvalheira JB, Pilla VF, Pareja JC, D´Albuquerque LAC. The Incapacity of the Surgeon to Identify NASH in Bariatric Surgery Makes Biopsy Mandatory [Internet]. Obesity surgery. 2009 ; 19( 12): 1678-1684.Available from: http://link.springer.com/article/10.1007/s11695-009-9980-x

    Referências citadas na obra
    Blackburn GL, Mun EC. Effects of weight loss surgeries on liver disease. Semin Liver Dis. 2004;24:371–9. Review.
    Day CP, James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology. 1998;114:842–5.
    Cortez-Pinto H, de Moura MC, Day CP. Non-alcoholic steatohepatitis: from cell biology to clinical practice. J Hepatol. 2006;44:197–208. Review.
    Pories WJ, MacDonald KG Jr, Morgan EJ, et al. Surgical treatment of obesity and its effect on diabetes: 10-year follow-up. Am J Clin Nutr. 1992;55:582S–5S.
    Dixon JB, Bhathal PS, Hughes NR, et al. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology. 2004;39:1647–54.
    Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol. 2006;45:600–6.
    Ong JP, Elariny H, Collantes R, et al. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg. 2005;15:310–5.
    Stratopoulos C, Papakonstantinou A, Terzis I, et al. Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity. Obes Surg. 2005;15:1154–60.
    Beymer C, Kowdley KV, Larson A, et al. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. Arch Surg. 2003;138:1240–4.
    Dixon JB, Bhathal PS, O’Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 2001;121:91–100.
    Moretto M, Kupski C, Mottin CC, et al. Hepatic steatosis in patients undergoing bariatric surgery and its relationship to body mass index and co-morbidities. Obes Surg. 2003;13:622–4.
    Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221–31. Review.
    Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006;40(Suppl 1):S5–10. Review.
    Dolce CJ, Russo M, Keller JE, et al. Does liver appearance predict histopathologic findings: prospective analysis of routine liver biopsies during bariatric surgery. Surg Obes Relat Dis. 2009;5:323–8.
    Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis. 2001;21:27–41. Review.
    Furuya CK Jr, de Oliveira CP, de Mello ES, et al. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years. J Gastroenterol Hepatol. 2007;22:510–4.
    Donnelly KL, Smith CI, Schwarzenberg SJ, et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115:1343–51.
    Sazci A, Akpinar G, Aygun C, et al. Association of apolipoprotein E polymorphisms in patients with non-alcoholic steatohepatitis. Dig Dis Sci. 2008;53:3218–24.
    Huang Y, Liu XQ, Rall SC Jr, et al. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia. J Biol Chem. 1998;273:26388–93.
    Wouters K, van Gorp PJ, Bieghs V, et al. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology. 2008;48:474–86.
    Frantzides CT, Carlson MA, Moore RE, et al. Effect of body mass index on nonalcoholic fatty liver disease in patients undergoing minimally invasive bariatric surgery. J Gastrointest Surg. 2004;8:849–55.
    Boza C, Riquelme A, Ibañez L, et al. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass. Obes Surg. 2005;15:1148–53.
    Helling TS, Helzberg JH, Nachnani JS, et al. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated? Surg Obes Relat Dis. 2008;4:612–7.
    Luyckx FH, Desaive C, Thiry A, et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord. 1998;22:222–6.
    Chitturi S, Farrell G, Frost L, et al. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? Hepatology. 2002;36:403–9.
    Geloneze B, Tambascia MA, Pareja JC, et al. Serum leptin levels after bariatric surgery across a range of glucose tolerance from normal to diabetes. Obes Surg. 2001;11:693–8.
    Björntorp P. Metabolic implications of body fat distribution. Diabetes Care. 1991;14:1132–43. Review.
    Vohl MC, Sladek R, Robitaille J, et al. A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. Obes Res. 2004;12:1217–22.
    Fujioka S, Matsuzawa Y, Tokunaga K, et al. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism. 1987;36:54–9.
    Kanai H, Matsuzawa Y, Kotani K, et al. Close correlation of intra-abdominal fat accumulation to hypertension in obese women. Hypertension. 1990;16:484–90.
    Collins D, Hogan AM, O’Shea D, et al. The omentum: anatomical, metabolic, and surgical aspects. J Gastrointest Surg. 2009;13:1138–46.